Citation:Lester JF, Macbeth FR, Toy E, Coles B 2006

Citation

Lester JF, Macbeth FR, Toy E, Coles B. Palliative radiotherapy regimens for non-small cell lung cancer. Cochrane Database Syst Rev 2006 Oct 18;(4):CD002143 Available from: http://www.ncbi.nlm.nih.gov/pubmed/17054152.

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Lester JF, Macbeth FR, Toy E, Coles B 2006	What is the clinical benefit of radiotherapy to the lung primary in stage IV NSCLC?	Associate Professor Shalini Vinod MBBS MD FRANZCR	completed
Lester JF, Macbeth FR, Toy E, Coles B 2006 2	What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy and who do not have a mutation for targeted therapy?	Dr Margot Lehman MBBS FRANZCR GDP	completed

Compare quality appraisals for each clinical question

• [[Clinical question:What is the clinical benefit of radiotherapy to the lung primary in Stage IV NSCLC?|]] (compare critical appraisals)
• [[Clinical question:What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy?|]] (compare critical appraisals)

Cited by

1. What is the optimal treatment approach for patients with stage III inoperable NSCLC who, because of patient or tumour factors, are not suitable for curative treatment with concurrent chemo-radiotherapy and who do not have a mutation for targeted therapy?